SCHEMBL4186045

SCHEMBL4186045

C[C@@H](CC1CCCC1)NCc1ccccc1NC(=O)c1ccc(F)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ALDH1A1 P00352 1/20 0.45
HPGD P15428 1/20 0.45
CTSL P07711 1/20 0.44
BCHE P06276 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
HTT P42858 1/20 0.43
KDM4E B2RXH2 2/20 0.42
LMNA P02545 2/20 0.42
DRD1 P21728 1/20 0.42
HRH2 P25021 1/20 0.42
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4193519 0.99 MEN1 (0.47) MEN1KMT2AALDH1A1HPGDCTSL
SCHEMBL4184490 0.99 MEN1 (0.47) MEN1KMT2AALDH1A1HPGDCTSL
SCHEMBL4189868 0.88 LDLR (0.46) MEN1KMT2AHPGDCTSLSMN1; SMN2
SCHEMBL4708572 0.88 SMN1; SMN2 (0.46) MEN1KMT2AALDH1A1HPGDNPSR1
SCHEMBL4758369 0.87 ACKR3 (0.45) MEN1KMT2AALDH1A1HPGDNPSR1
SCHEMBL4192323 0.87 KMT2A (0.44) KMT2AALDH1A1CTSLNPSR1KDM4E
SCHEMBL4186006 0.87 KMT2A (0.44) KMT2AALDH1A1CTSLNPSR1KDM4E
SCHEMBL4198225 0.86 CTSL (0.44) KMT2AALDH1A1CTSLNPSR1KDM4E
SCHEMBL4197332 0.86 CTSL (0.44) KMT2AALDH1A1CTSLNPSR1KDM4E
SCHEMBL4190624 0.86 CTSL (0.44) KMT2AALDH1A1CTSLNPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 MEN1 3776/4885KMT2A 2047/4885ALDH1A1 2744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.